Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00907257 · ClinicalTrials.gov registry record · Phase 4
A Study of Different Use Regimens Using Two Acne Treatments
A Phase 4 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 4
- Development phase
- 247
- Enrollment target
NCT00907257: Completed Phase 4 study, sponsored by Bausch Health Americas.
NCT00907257 is a Phase 4 study that has completed, run by Bausch Health Americas. The registered enrollment target is 247 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (52% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00907257, a Phase 4 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 247 participants
- Enrollment target
Study Summary
A study to determine if using 2 acne products in the morning is as safe and efficacious as using one product in the morning and one product in the evening.
Primary Outcome
Total Facial Acne Lesion Count is the sum of non-inflammatory and inflammatory lesions, plus nodules/cysts. Change from Baseline is calculated as the value after Baseline minus the baseline value, and negative values indicate improvement.
Interventions
- DRUG Tretinoin gel
- DRUG benzoyl peroxide wash
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 247 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-09 |
| Phase | Phase 4 |
What the finished NCT00907257 record still lists
NCT00907257 is an interventional study that assigns participants to a tested intervention. The registered 247 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (52% lower).
The record links to 0 conditions, and to 2 interventions - of which Tretinoin gel is the first listed.
NCT00907257 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00907257 about?
NCT00907257 is a clinical study titled "A Study of Different Use Regimens Using Two Acne Treatments". A study to determine if using 2 acne products in the morning is as safe and efficacious as using one product in the morning and one product in the evening.
What is the current status of trial NCT00907257?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 247 participants. The study started on 2009-02. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00907257?
The interventions under investigation include: Tretinoin gel (DRUG), benzoyl peroxide wash (DRUG).
Who is sponsoring clinical trial NCT00907257?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00907257's enrollment target sits among peer trials
247 355th of 2000 higher than 1,645 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04269902 · 247 participants · Phase 3
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
- NCT04989803 · 247 participants · Phase 1
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma
- NCT05521399 · 247 participants
Heart Transplantation - Renewal
- NCT05556824 · 247 participants · Phase 2
Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia